AZTR Stock Jumps As Azitra Confirms 1-For-10 Reverse Split
Azitra Inc. (AZTR) stock surged after announcing a 1-for-10 reverse split, reducing its share count from 60.6M to 6.06M. The move aims to maintain NYSE American listing standards. AZTR reported a quarterly net loss of $3.35M with $6.7M in cash. The stock is highly volatile, trading at $1.53 after a significant intraday move.
How this was made

The 30-second read
Why it matters
The reverse split is intended to keep the stock listed by moving it out of the sub‑dollar range, which historically triggers heightened short‑term trading activity.
Market read
The split creates a short‑term trading opportunity but does not alter the underlying business fundamentals.
What to watch
Liquidity may dry up post‑split, increasing execution risk for larger orders.
Background
Azitra Inc is a development‑stage dermatology biotech trading as a micro‑cap on NYSE American. The company has no revenue and carries a small cash runway.
Ticker impact
Azitra Inc announced a 1-for-10 reverse stock split effective Oct 26, 2026, changing its float and share price.
potential upward pressure as the higher per‑share price attracts buyers, but also risk of sharp pullbacks due to thin float.
Reverse splits on micro‑caps typically create a volatility pocket; the new higher price and reduced share count amplify order flow.
Market effects
May prompt other low‑price biotech micro‑caps to consider similar moves to avoid delisting.
Limited to US OTC/NYSE American market; no broader regional effect.
Minimal global impact; primarily a micro‑cap specific event.
Counterpoint
If confidence in Azitra's pipeline wanes, the higher price could accelerate a sell‑off, making short positions attractive.
Key entities
- companyAzitra Inc
Micro‑cap biotech undergoing a 1‑for‑10 reverse split.

